LKL International Berhad, an investment holding company, (0182) Fair Value & Analysis
Healthcare · MY · Market cap 13.6M MYR
Fair value as of: Jun 26, 2026
Analysis
LKL International Berhad, an investment holding company, (0182) currently trades at 0.0350 MYR, while our model-based Fair Value estimate is 0.0858 MYR — implying the stock looks roughly 145.0% undervalued today. We read business quality at 96/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
LKL International Berhad, an investment holding company, engages in the manufacturing of medical and healthcare beds, medical peripherals, and accessories in Malaysia, Africa, Europe, the Middle East, and the rest of Asia. It operates through three segments: Manufacturing, Trading, and Retail. The company offers A&E patient transport trolley, cart and trolley, curtain track, delivery bed, examination table, instrument trolley, manual crank bed, medical chair, nursery equipment, and patient room furniture, as well as hospital electrical bed, hospital hydraulic bed, and hospital ICU and CCU electrical bed; and miscellaneous hospital equipment, such as x-ray viewer, concealment collection table, and surgical bowl stand. It also provides a range of drugs, chemicals, alkalis, cosmetics, personal care, health food, medical device, manure antibodies, and pharmaceutical medicine through its retail pharmacy business; and management and advisory services. In addition, the company is involved …
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is LKL International Berhad, an investment holding company, (0182) undervalued?
What is the fair value of 0182?
What is the quality score of 0182?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.